Kommersant: production of the vaccine "KoviVac" was suspended in Russia

The material notes that the developer of the drug has closed the site for modernization where the raw materials for the drug are produced.

According to Sergey Shulyak, general director of DSM Group, the installation of new equipment is underway, with the help of which production volumes will be increased.

“The demand for this vaccine turned out to be paradoxically high,” said Nikolay Bespalov, Development Director of RNC Pharma.

In addition, there is an assumption that the suspension of production of "KoviVac" is connected with the intention of the center to prepare it for export.

Earlier, the director of the Chumakov Center, Aydar Ishmukhametov, in an interview with RT, spoke about the work on a vaccine against the delta strain of coronavirus.

Earlier, Georgy Vikulov, director of the Research Center for the Prevention and Treatment of Viral Infections, commented on reports that the Chumakov Center plans to change the KoviVac vaccine for the delta strain.